873947-64-9Relevant academic research and scientific papers
NK1 ANTAGONISTS
-
Page/Page column 84, (2010/02/15)
A compound having the general structure shown in Formula (I) or pharmaceutically acceptable salts and/or solvates thereof are useful in treating diseases or conditions mediated by NK1 receptors, for example various physiological disorders, symp
BRIDGED RING NK1 ANTAGONISTS
-
Page/Page column 146-147, (2010/11/08)
A compound having the general structure shown in Formula (I): or pharmaceutically acceptable salts and/or solvates thereof are useful in treating diseases or conditions mediated by NK1 receptors, for example various physiological disorders, symptoms or di
